๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

โœ Scribed by Thomas D. Boyer; Ziv J. Haskal


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
160 KB
Volume
41
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


The recommendations in this article provide a datasupported approach. They are based on the following: (1) a formal review and analysis of recently published world literature on the topic (as listed in MEDLINE); (2) the American College of Physicians' A Manual for Assessing Health Practices and Designing Practice Guidelines 1 ; (3) policy guidelines, including the American Association for the Study of Liver Diseases' Policy Statement on Development and Use of Practice Guidelines and the American Gastroenterological Association's Policy Statement on the Use of Medical Practice Guidelines 2 ; and (4) the authors' years of experience in the care of patients with portal hypertension and use of transjugular intrahepatic portosystemic shunt in the management of these disorders. These recommendations are fully endorsed by the American Association for the Study of Liver Diseases and the Society for Interventional Radiology.

Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventative aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies designed to be followed in every case. Specific recommendations are based on relevant published information. In an attempt to characterize the quality of evidence supporting recommendations, the Practice Guidelines Committee of the American Association for the Study of Liver Diseases requires a grade to be assigned and reported with each recommendation (Table 1).


๐Ÿ“œ SIMILAR VOLUMES


Decision-analysis of transjugular intrah
โœ Steven L. Zacks; Robert S. Sandler; Andrea K. Biddle; Matthew A. Mauro; Robert S ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB

Transjugular intrahepatic portosystemic shunt (TIPS) and surgical distal splenorenal shunt (DSRS) are treatments for complications of portal hypertension. TIPS is widely used because it is relatively easy to place. Because TIPS may malfunction over time, it is unclear whether TIPS is superior to DSR

The hematologic consequences of transjug
โœ A J Sanyal; A M Freedman; P P Purdum; M L Shiffman; V A Luketic ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 340 KB

jects. However, it is self-limited and rarely requires SEE EDITORIAL ON PAGE 177. intervention. Potential mechanisms of such hemolysis are discussed. TIPS is also not recommended as a means of improving platelet counts in patients with Transjugular intrahepatic portosystemic shunts (TIPS) severe hyp

Transjugular intrahepatic portosystemic
โœ Michael J. Wallace; David C. Madoff; Kamran Ahrar; Carla L. Warneke ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB

## BACKGROUND. Transjugular intrahepatic portosystemic shunt (TIPS) placement has emerged as an effective and minimally invasive method of treating portal hypertension and its associated complications. To the authors' knowledge there is limited documentation of its use for percutaneous shunting in